Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesHeramed Ltd

Heramed Ltd

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.037 AUD 0.00(0%)
Last update at 2026-11-06T02:42:00Z
VOLUME
39558
Market Cap
42.87M

Momentum Score

…

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.04
Low
0.04
High
52 Week Price Range
0.03
Low
0.06
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Publicly available information on Heramed Ltd (ASX: HMD) is limited, and the company's core business activities and products are not well-documented in readily accessible sources. Investors should consult the company's regulatory filings and announcements for authoritative detail; the stock may offer exposure to a small-cap company that could benefit if disclosed strategic initiatives and execution prove successful.
Material risks include limited disclosure and transparency, low market liquidity, and execution or financing risk if the business is at an early or developing stage.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.04
Dividend Yield
-
Revenue TTM
0.33M
Revenue Per Share
-
Gross Profit TTM
-0.05M
Debt / Equity
0.03
ROE
-223.73%
Net Debt
-0.91M
ROCE
-340.98%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -2.76M -3.40M -4.62M -4.88M -5.71M
Net income -2.76M -3.40M -4.50M -6.62M -7.38M
Selling general administrative - 1.63M 1.70M 1.71M 1.73M
Selling and marketing expenses - 1.22M 1.13M 0.50M 0.46M
Gross profit - 0.14M 0.25M 0.14M 0.04M
Reconciled depreciation - 0.33M 0.44M 0.36M 0.27M
Ebit -2.66M -3.37M -4.41M -3.14M -3.94M
Ebitda -2.56M -3.35M -3.97M -2.78M -3.67M
Depreciation and amortization 0.10M 0.02M 0.44M 0.36M 0.27M
Operating income -2.66M -5.57M -4.55M -3.14M -3.94M
Other operating expenses 2.85M 5.93M 4.96M 3.40M 4.03M
Interest expense 0.00M 0.05M 0.09M 1.74M 1.67M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 0.01M 0.02M 0.04M 1.67M
Net interest income - -0.04M -0.07M -1.70M -1.67M
Income tax expense - - 0.00M 1.74M 1.67M
Total revenue 0.20M 0.23M 0.41M 0.22M 0.09M
Total operating expenses 2.76M 5.79M 4.79M 3.32M 3.98M
Cost of revenue - 0.09M 0.17M 0.08M 0.04M
Total other income expense net -0.10M -0.02M -0.07M -1.74M -1.77M
Net income from continuing ops - -5.49M -4.50M -4.88M -5.71M
Net income applicable to common shares - -5.49M -6.78M -4.88M -5.71M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.99M 2.78M 2.95M 4.16M 4.59M
Intangible assets - 0.73M - 1.04M 0.67M
Other current assets 0.02M 0.09M - - 0.04M
Total liab 0.22M 1.06M 2.27M 1.30M 4.70M
Total stockholder equity 0.62M 1.72M 0.68M 2.86M -0.11M
Deferred long term liab - - - 1.04M 0.67M
Other current liab 0.14M 0.41M 0.05M 0.05M 0.03M
Common stock 27.66M 24.10M 35.33M 22.16M 16.48M
Capital stock - 38.93M - 22.16M 16.48M
Retained earnings -29.48M -28.67M -42.12M -24.24M -19.36M
Other liab - - - 0.50M 0.55M
Other assets - - 0.00M 1.04M 0.67M
Cash 0.91M 1.94M 1.06M 2.62M 3.56M
Total current liabilities 0.22M 0.65M 1.51M 0.79M 4.15M
Current deferred revenue - - 0.00M - -
Net debt -0.91M -1.89M -0.80M -2.44M -0.14M
Short term debt - 0.05M 0.26M 0.18M 3.42M
Short long term debt - 0.16M - 0.18M 3.42M
Short long term debt total - 0.05M 0.26M 0.18M 3.42M
Other stockholder equity - -0.00M 0.00M 0.09M 2.77M
Property plant equipment - - - 0.08M 0.03M
Total current assets 0.97M 2.30M 1.93M 3.04M 3.89M
Net tangible assets - - - 2.86M -0.78M
Short term investments - 0.02M - 0.02M 0.03M
Net receivables 0.03M 0.02M 0.50M 0.25M 0.24M
Long term debt - 0.66M - - 0.00M
Inventory - 0.23M 0.36M 0.17M 0.09M
Accounts payable 0.07M 0.19M 1.20M 0.56M 0.69M
Accumulated other comprehensive income 2.45M 6.29M 7.47M 4.94M 2.77M
Non currrent assets other 0.03M 0.45M 0.95M - 0.00M
Non current assets total 0.03M 0.48M 1.03M 1.11M 0.70M
Long term debt total - - - 0.00M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00M -0.00M -0.69M -0.09M
Change to liabilities - - - 0.00M 0.19M
Total cashflows from investing activities - 0.00M -0.00M -0.69M -0.09M
Net borrowings - -0.20M - -0.10M 1.69M
Total cash from financing activities 1.27M 6.88M 2.96M 2.54M 4.88M
Net income -2.76M -3.40M -4.50M -6.62M -5.71M
Change in cash -1.17M 1.21M -2.78M -0.94M 1.66M
Begin period cash flow 2.09M 0.72M 2.62M 3.56M 1.90M
End period cash flow 0.91M 1.94M 0.72M 2.62M 3.56M
Total cash from operating activities -2.44M -4.81M -5.57M -6.26M -3.23M
Issuance of capital stock - 7.08M 2.12M 2.64M 3.31M
Depreciation 0.10M 0.20M 0.66M 0.36M 0.27M
Other cashflows from investing activities - - -0.00M - -
Change to inventory - -0.01M -0.10M - -0.02M
Change to account receivables 0.05M 0.18M -0.09M - -0.01M
Sale purchase of stock - 7.08M 3.19M 2.64M 3.31M
Other cashflows from financing activities - -0.08M 0.95M -0.10M 1.69M
Change to netincome - - - - 2.21M
Capital expenditures 0.00M 0.00M 0.00M 0.69M 0.09M
Change in working capital -0.36M 0.17M -0.10M 0.02M 0.00M
Stock based compensation - 0.22M 0.02M - -
Other non cash items 0.58M -2.01M -1.00M 6.26M 5.44M
Free cash flow -2.44M -2.98M -5.57M -6.95M -3.32M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
HMD
Heramed Ltd		 -
-%		 0.04 - - 129.73 17.41 138.46 -7.84
COH
Cochlear Ltd		 1.03
0.67%		 155.47 68.64 27.40 4.30 5.34 3.97 28.09
IMR
Imricor Medical Systems Inc		 -0.03
2.29%		 1.28 - - 36401.21 17.45 4019.33 -2.60
AVR
Anteris Technologies Global Corp		 -0.36
4.21%		 8.20 - - 356.02 2.19 130.34 -5.20
AVH
Avita Medical Inc		 -0.08
1.73%		 4.55 - 9.97 9.59 7.17 6.76 15.37

Profile*

Heramed Ltd

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.

117 Camberwell Road, Hawthorn East, VIC, Australia, 3123

61 2 7251 1888

https://www.hera-med.com

Name Title Year Born
Mr. David Groberman Co-Founder, CEO & Exec. Director NA
Mr. Tal Slonim Co-Founder, COO & Exec. Director NA
Ms. Sivan Sadan Chief Financial Officer NA
Mr. Michael Nenner Chief Technology Officer NA
Henry Jordan Head of Investor Relations NA
Mr. Ariel Laden VP of Marketing NA
Dr. Josef Tovbin Chief Medical Officer NA
Mr. Jonathan Hart B.Com., L.L.B. Company Sec. NA
Dr. Ronald Peter Weinberger AIMM, BSc (Hons), Ph.D. Executive Chairman NA
Dr. Ronald Peter Weinberger AIMM, BSc (Hons), Ph.D. Executive Chairman NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…